Aims: Current limitations of tissue-engineered vascular grafts include timing for the scaffold preparation, cell type, cell differentiation and growth inside the construct, and thrombogenicity of the final device. To surmount these shortcomings, we developed a heparin-releasing poly-l-lactide (PLLA) scaffold using the electrospinning technique, to guide the differentiation of human mesenchymal stem cells towards the endothelial phenotype and to deliver a useful drug in the management of the postimplantation period.
Heparin-releasing scaffold for stem cells: a differentiating device for vascular aims
In vascular tissue engineering, the goal is to provide a functional living artery for the replacement of diseased small-caliber arteries. Current artificial grafts present significant shortcomings, including thrombosis, infection, limited durability and an inability to grow. To overcome these limitations, tissue-engineered vascular graft (TEVG) constructs have been developed by using cultured autologous vascular wall cells seeded onto a synthetic biodegradable polymeric scaffold [1] . The main advantages of autologous TEVGs are increased cell growth, construct durability and resistance to infections, but they are still harnessed by limitations regarding thrombogenicity and donor scarcity. Both preclinical and clinical studies have demonstrated the feasibility of constructing functional vascular grafts from autologous vascular cells seeded onto a biodegradable tubular matrix with a large diameter (Ø > 6 mm) [2] .
Several types of polymeric biomaterials have been proposed to obtain vascular grafts. Polyl-lactide (PLLA) and poly(lactide-co-glycolide) represent the most attractive avenues for these purposes owing to their adequate mechanical properties and biocompatibility [3] . In addition, PLLA and poly(lactide-co-glycolide) are bioabsorbable, allowing in vivo vascular cell remodeling to generate a final, functional conduit. During the degradation and remodeling process, the synthetic construct contributes by conferring adequate strength to the conduit, preventing aneurysmal degeneration and rupture [4] .
Many different techniques have been developed for the fabrication of vascular scaffolds with biopolymers [5] . Electrospinning is one of the most effective and functional approaches, with the possibility to be combined to the newest methodologies of cell seeding [6] . The small-diameter fibers produced by electrospinning exhibit a large specific surface area as well as high permeability, both desirable in a biological setting [7] .
Nano-and microfibrous electrospun scaffolds, mimicking the arrangement of connective tissue fibrillar proteins, have been demonstrated to allow the remodeling of vascular grafts in both cellular and extracellular content, thus representing an optimal candidate for TEVG fabrication [8] . Biopolymers loaded with growth factors, cytokines and drugs have also been developed, future science group generating drug-releasing systems capable of localized delivery of molecules [9, 10] . However, several issues concerning the clinical applications of TEVGs still need to be answered. Reasonable and clinically suitable timing for scaffold preparation, mechanical properties, cell type, differentiation and growth inside the construct, and thrombogenicity represent the major concerns.
Lack of cell attachment factors, present in naturally derived scaffolds [11] , along with poor cellularity and survival within the scaffold itself, may lead to a nonuniform endothelialization within areas of a denuded graft that could trigger thrombogenic phenomena. Glycosaminoglycans, which include chondroitin, dermatan, heparan and heparin sulfate, play a crucial role in favoring endothelial cell adhesion and proliferation, and inhibiting smooth muscle cell proliferation and migration, following injury or inflammation. In addition, antithrombotic properties of glycosaminoglycans are well characterized [12] .
Several autologous cell types have been used to seed engineered scaffolds. Endothelial cells obtained from the great saphenous vein are frequently used, although cell yield and availability are limited [13] . Moreover, the minimum time from harvesting autologous cells to the production of a mature and durable conduit is approximately 8 weeks [14] . This approach is limited to elective procedures and requires local expertise, bioreactor facilities and consideration of issues concerning the patency rate of the graft; in several animal models, the use of engineered scaffolds, or even small intestine submucosa, has shown an overall patency rate of 75% after 48 weeks, even using aspirin and warfarin [4] .
The greatest obstacles to the widespread use of TEVGs in clinical practice are the lack of offthe-shelf availability and the difficulties in harvesting and propagating autologous cells. These problems are especially daunting in vascular surgery, where treatment of an acutely ischemic lower limb is involved.
In this context, the use of adult stem cells is an attractive alternative, owing to their easy availability in clinical settings (i.e., through bone marrow aspiration) and their notable plasticity that make them suitable for 'bench-to-bedside' applications. Human mesenchymal stem cells (hMSCs) from bone marrow have been demonstrated to be a suitable candidate for tissue regeneration, including vascular, cardiac [15] and bone tissue [16] . Recently, they have been demonstrated to exhibit antithrombogenic properties, especially in relation to their cell-surface heparan sulfate proteoglycans [8] .
In this scenario, we developed an electrospun, heparin-releasing PLLA tubular scaffold that was seeded with hMSCs and assayed in terms of cytotoxicity, cell survival, proliferation and differentiation. This scaffold was developed with the aim to both guide the differentiation of stem cells towards endothelium and deliver factors useful in the management of the postimplantation period.
Materials & methods n Scaffold preparation
A PLLA/Hep scaffold was prepared by electrospinning, starting from a 13% w/w PLLA (Sigma, Milwaukee, WI, USA) solution in dichloromethane (Sigma). Unfractioned heparin (sodium salt, 5000 IU/ml, MSPharma, Gaither, MD, USA) was added to the polymer solution using methanol (Sigma) as a co-solvent to obtain a final heparin concentration (with respect to PLLA) of 250 UI/g. This concentration was chosen according to both literature and clinical dosage [17] in order to create a device suitable for direct clinical application. The solution was fed through a 28 G needle with a feed rate of 1.5 ml/h and electrospun (DynaSpin, Biomatica, Rome, Italy) onto an earthed collector placed at a distance of 15 cm, using a voltage of 15 kV. In order to achieve tubular scaffolds, a rotating cylindrical AISI 316L stainless steel mandrel (4 mm diameter and 6 cm length, rotating at 4500 rpm) was used as the collector target.
In addition, a bare PLLA scaffold (PLLA/ctrl), without heparin addition, was obtained with the same experimental conditions to be used as a control for the biological assessments. Microstructure of the obtained materials was evaluated by field-emission scanning electron microscopy (FE-SEM; Supra™ 1535, Leo Electron Microscopy, Cambridge, UK). Image ana lysis of FE-SEM micrographs was performed by means of the accompanying software.
Autofluorescence ana lysis on the polymer itself was performed in order to assess potential biases or artifacts in further processing for immunostaining. Polymers were excited at different time points within a range spanning between 10 ms and 10 s and autofluorescence was detected under a fluorescence microscope (Olympus, Tokyo, Japan). n Drug release study Heparin release rate was measured using a colorimetric assay [18] . A total of 40 mg of PLLA/Hep scaffold was placed in a 15 ml sealed tube with future science group 800 µl of prewarmed phosphate -buffered saline (PBS) containing 0.03% w/v NaN 3 and incubated at 37°C. The 60-µl aliquots of supernatant were timely collected and quantified according to the aforementioned assay.
Activity of heparin was assessed by activated coagulation time (ACT), determined in blood samples exposed to the eluted heparin. A total of 50 mg of PLLA/Hep and PLLA/ctrl samples were separately placed in two sealed vials containing 500 µl of normal saline, and incubated for 24 h at 37°C. A total of 100 µl of each surnatant were added to 1 ml of freshly collected blood and ACT was measured using an automated coagulation analyzer (ACT II, Medtronic, Fridley, MN, USA). n Mechanical properties Mechanical tests were performed on PLLA/Hep electrospun grafts. Measurements included static compliance, circumferential and longitudinal uniaxial tensile properties, and suture retention [19] [20] [21] .
For circumferential characterization, each construct was cut in rings that were measured by means of a dial caliper. Rings were inserted with two stainless-steel flat hooks that were fixed to the clamps of the testing device (TH2730, Thumler, Nurnberg, Germany) equipped with a force transducer (Nordisk Transducer Teknik, Hadsund, Denmark) and pulled at 10 mm/min crosshead speed until sample failure. Loaddisplacement data were computed to obtain stress-strain curves starting from specimen geometrical parameters.
According to Nieponice et al., ultimate tensile stress and strain to failure were considered as the maximum stress value before failure and its corresponding value of strain, respectively [22] . Burst pressure (P b ) was also estimated from ultimate tensile stress using the following law:
where D 0 is the initial diameter of the sample and t is the initial thickness of the tested scaffold. For longitudinal testing, constructs were cut longitudinally and flattened into a rectangular shape. A 'dog bone' shaped specimen of known geometry was then cut from the rectangular sample and its terminations connected to the clamps of the tensile tester. The test was performed at an extension rate of 10 mm/min. Peak stress and longitudinal strain at failure were calculated starting from load-displacement data collected in the tests [19] .
Static compliance tests were performed according to Stankus et al. [21] , mounting constructs in a hydraulic circuit and subjecting them to a pressure ramp (0-250 mmHg) by means of a syringe pump (KD Scientific, Holliston, MA, USA) infusing PBS at a constant rate (4 ml/min), while the circuit was clamped downstream. Pressure was monitored using a pressure transducer (40PC100G1A, Honeywell, Freeport, IL, USA) connected to the hydraulic circuit, while the outer diameter was measured by using a high-resolution camera and processing the acquired images with an ana lysis tool (ImageTool 3.0, UTHSCSA, San Antonio, TX, USA). Samples were preconditioned by clogging the porosity with a high-viscosity freezing medium (OCT Embedding Matrix, CellPath, Newton Pawys, SY, USA). Static compliance was calculated as specified in the ANSI 7198 standard [19, 23] , and reported as percent per 100 mmHg:
where the inner diameter was estimated starting from the measured outer diameter and using the assumption of incompressibility of cross-sectional area (A):
Finally, suture retention tests were performed on samples at an extension rate of 150 mm/min in accordance with ANSI/AAMI VP20-1994 [19] . Geometrical characteristics were measured by means of a dial caliper. A single commercial 6.0 prolene loop (Ethicon, Inc., Somerville, NJ, USA) was placed 2 mm from the end of the sample and secured to the upper clamp of the testing device. Suture retention force was considered as the maximum force recorded prior to failure, while the suture retention tension was obtained by normalizing the retention force by sample thickness [21] . n Cell seeding Human mesenchymal stem cells (passage 4, Lonza, Basel, Switzerland) were used for seeding on a tubular PLLA/Hep scaffold (4 mm inner diameter, 0.5 mm wall thickness and 5 cm length). Similar experiments were performed on PLLA/ctrl tubular scaffolds as a control for differentiation induction. Prior to cell culture, both PLLA/ctrl and PLLA/Hep scaffolds were sterilized by soaking in absolute ethanol [9] and future science group rinsing in sterile PBS. Scaffolds were seeded with hMSCs under rotating dynamic conditions (12 g) to guarantee uniform cell distribution, at a density of 500 × 10 3 cells/cm 2 in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum, 100 units/ml penicillin, 100 µg/ml streptomycin (Lonza) and incubated for 48 h [24] . To standardize culturing protocol and normalize subsequent biological analyses and assessments, seeding efficiency was calculated as previously described [25] . Briefly, after the seeding of each sample, the medium exuded through the scaffold was collected and used for cell counting with a hematocytometer to calculate seeding efficiency as the percentage of the initial number of cells entrapped within the scaffold over the total amount of seeded cells. To confirm phenotype permanence, additional experiments were performed culturing the constructs for up to 1 week.
In addition, control cultures were performed on conventional culture plates, exposing the hMSCs to the elution products of the scaffolds; cells were seeded at the same cellular density of 500 × 10 3 cells/cm 2 onto transwell inserts, and cultured in the same conditions while exposed to PLLA/Hep and PLLA/ctrl scaffolds. n Cell engraftment Cell engraftment within the constructs was evaluated by immunohistology and confocal microscopy. Upon culturing, tubular scaffolds were fixed with 4% paraformaldehyde for 15 min, embedded in OCT cryomatrix, snap frozen and cut in 15 µm slices. To assess cell attachment and engraftment, confocal microscopy was performed, staining cells for F-actin with rhodamine phalloidin (Molecular Probes, Invitrogen, San Diego, CA, USA) using TOTO ® (Invitrogen) as nuclear counterstain.
For cell viability assessment, a Live/Dead ® assay (Invitrogen), based on cellular membrane intactness, was used. Percentage of viable cells was calculated by counting at least 200 cells in ten randomly chosen microscopic fields at 10× magnification. Data are presented as the mean value ± standard deviation. n Cell proliferation Cell proliferation was evaluated by measuring the total cellular DNA content as well as semiquantitatively immunostaining for Ki67 by confocal microscopy. Cellular DNA content was obtained as previously described [26] . Constructs were collected and media removed. Constructs were lysed in RIPA buffer supplemented with protease inhibitor cocktail Halt (Thermo Fisher Scientific, Rockford, IL, USA) and cells were sonicated using a pulsed ultrasonic disruptor (Thermo Fisher Scientific) three times for 10 s. DNA content was measured using Quant-iT™ dsDNA assay kit (Invitrogen) on a Qubit ® fluorimeter (Invitrogen). n Cell differentiation Single immunostaining for CD31 and von Willebrand factor (vWF; Abcam, Cambridge, UK) and double for Ki67 and CD31 (NeoMarkers, Fremont, CA, USA) were performed as previously described [27] . Briefly, tissue sections were permeabilized with 0.1% Triton-X100 (Sigma) in PBS for 10 min. Nonspecific binding of antibodies was blocked by incubating the samples for 45 min with 2% bovine serum albumin (Sigma). Samples were incubated for 1 h at 37°C with mouse monoclonal anti-CD31 (1/100 dilution) and rabbit anti-Ki67 (1/100 dilution) primary antibodies. Samples were then incubated with AlexaFluor ® 488-conjugated secondary antimouse IgG and AlexaFluor ® 546-conjugated secondary anti-rabbit IgG (Invitrogen) for 30 min at 37°C. In negative-control experiments, the incubation with primary antibodies was omitted. Nuclei were counter-stained with TOTO. Samples were then mounted in ProLong Antifade medium (Invitrogen) and viewed under an Olympus Fluorview F1000 confocal microscope by two independent blinded observers.
Flow cytometry for CD31 expression was performed on hMSCs cultured on PLLA/Hep and PLLA/ctrl scaffolds, using CD29 (neomarkers) as a positive control [28] . The same experiment was also performed on hMSCs cultured in adherence on transwell inserts and exposed to PLLA/Hep and PLLA/ctrl scaffolds, in order to evaluate the biological effectiveness of heparin release. Cells were detached by mild trypsinization and run through a flow cytometer (Accuri Cytometers, Ann Arbor, MI, USA). A minimum of 50,000 events were collected and acquired in a list mode with the accompanying software. Acquired data were analyzed using CellQuest software (BD BioSciences, San Jose, CA, USA).
In addition, total protein content was extracted from constructs and evaluated by western blot ana lysis and densitometry ana lysis as previously described [27] using a CD31 monoclonal antibody. Briefly, protein concentration was determined by the bicinchoninic acid method and a total protein amount of 25 µg of the lysates were subjected to 8% SDS-PAGE (Sigma) and transferred onto 0.20 µm nitrocellulose membranes (Pierce Biotechnology, Rockford, IL, USA). Membranes were blocked in tris-buffered saline future science group protein-free solution (tris-buffered saline, pH 7.4 and 0.05% Tween 20™ + Kathon antimicrobial agent; Pierce Biotechnology) and were immunoblotted with the primary antibody overnight, followed by horseradish peroxidase-conjugated secondary antibodies anti-mouse IgG (Zymed Laboratories, South San Francisco, CA, USA). Membranes were exposed on radiographic film using an enhanced chemiluminescent substrate SuperSignal West Pico Trial Kit (Pierce Biotechnology). Densitometry ana lysis was performed using Image-Pro 6.0 (Media Cybernetics, Silver Spring, MD, USA). Figure 1A shows one of the obtained tubular scaffolds on the mandrel. FE-SEM micrographs of PLLA/Hep and PLLA/ctrl electrospun scaffolds are presented in Figure 1B & C, respectively. Both scaffolds consist of a nonwoven fibrous mesh, with porosity in the range of 10 µm, but significant differences can be found in fiber morpho logy. PLLA/ctrl sample shows micronsized fibers (average diameter of 1.5 ± 0.9 µm) and an intrinsic porosity, with elongated pores of approximately 100 µm in size. The PLLA/Hep scaffold, instead, shows fibers with smaller diameters (average diameter 450 ± 150 nm) and a nonporous structure.
Results n Scaffold characterization
Polymers were investigated in terms of autofluorescence, to prevent potential artifacts in further analyses. Scaffolds demonstrated autofluorescence only after 8.0 ± 0.4 s. n Drug release study The cumulative release of heparin from the PLLA/Hep scaffold was assessed by a colori metric assay, originally developed by Jaques et al. [29] and modified by Yang et al. [30] . Figure 2A shows heparin release profile. This assay is based on the metachromatic behavior of Azure A dye, which presents a shift towards shorter wavelengths (from 620 to 520 nm) of the absorption band when reacting with heparin. This reaction is primarily dependent upon the formation of a bond between amino groups of the dye and carboxylic groups of heparin.
An initial releasing burst in the first 24 h was detected. Subsequently, a progressive decrease in the release rate was noticed up to 4 weeks after with a cumulative release of approximately 10% of the total drug load. ACT assay confirmed an increase in coagulation time after exposure to scaffold-eluted heparin (450 s for PLLA/Hep vs 110 s for PLLA/ctrl; p < 0.05), as reported in Figure 2B .
n Mechanical properties Figure 3 shows the typical stress-strain curve obtained by circumferential testing on a PLLA/Hep sample. Nuclei appeared enlarged with loose chromatin and several nucleoli, indicating conditions of nonquiescence. Moreover, membranes demonstrated characteristic indentations and invaginations that resemble caveolae, typical of endothelial cells. The 3D rendering demonstrates full-thickness engraftment and cell migration (Figure 4e ). Cell proliferation, as evaluated by measuring the total DNA content per construct, demonstrated a statistically significant increase in the PLLA/Hep scaffold with respect to the PLLA/ctrl sample used as control ( Figure 4F ). This was also observed for cells cultured on transwell inserts and exposed to PLLA/Hep scaffolds not seeded with cells (p < 0.01).
Immunof luorescence ana lysis performed on the PLLA/Hep constructs revealed CD31 expression, along with Ki67-positive cells (Figure 5A -C) that were not found in the control ( Figure 5D ). In our tubular scaffolds, CD31-positive cells could be detected on the luminal surface of the construct. Flow cytometry confirmed and quantified CD31 positivity, demonstrating a statistically significant higher level of expression in the PLLA/Hep scaffold (Figure 5e ). Interestingly, a significant increase in CD31 positivity could be observed in cells exposed to PLLA/Hep scaffolds in comparison with PLLA/ctrl ones. These findings were confirmed by western blot ana lysis, followed by semiquantitative densitometric evaluation ( Figure 5F ). Extension of culturing time to 1 week confirmed the permanence of CD31 positivity. In addition, cells on the functionalized constructs expressed vWF, a late marker of endo thelial phenotype. In these studies, vWF localized both in the membrane and in cell cytoplasm, reliably indicating an immature form of the protein waiting for its definitive membrane migration (Figure 6 ).
Discussion
In vascular tissue engineering, the lack of cell retention and attachment could lead to unsuccessful results -especially when the grafts are exposed to pulsatile flow -with a reported cell loss usually detectable within the first 45 min [14] and retention rates as low as 4% [31] . Poor adhesion and cellularity within the scaffold, together with intrinsic thrombogenicity of the materials used, are the basis of the reduced patency rate of TEVGs. Aiming to regenerate or replace tissues, a good piece of literature currently focuses on developing 3D bioabsorbable scaffolds, to reproduce the extracellular matrix (ECM) structure and topography, and to provide a biological future science group support to guide cell attachment and proliferation [32] . To this extent, the electrospinning technique is a widely accepted method for producing biopolymeric scaffolds that remarkably mimic the size and scale of the natural ECM. It enables the fabrication of structures with submicron pores and nanotopography, which have been reported to be optimal in the synthesis of successful ECM-like scaffolds for cardiovascular tissue engineering using both stem and nonstem cells. Electrospun polymers are amenable to be functionalized with different drugs [5] .
Heparin plays a crucial role in endothelial cell adhesion and homeostasis, and is likely to improve cell attachment to the scaffold, providing trophic and differentiating signaling [12] . In addition, the time and dose-controlled release of this molecule from the construct could overcome issues concerning early thrombosis [31] . Furthermore, heparin is known to specifically bind various angiogenic growth factors, such as VEGF and basic FGF. Owing to these specific interactions, heparin could be reliably considered as playing a depot role within the ECM for growth factors, enhancing their stability against thermal denaturation and enzymatic digestion at physiological conditions [33] and enabling them to diffuse in a sustained manner. Several studies have been focused on the controlled release of growth factors using heparin-conjugated natural polysaccharides, such as alginate, chitosan and hyaluronic acid engineered as hydrogel matrices [34] , with the aim of injecting them into a desired tissue defect to induce local angiogenesis [35] .
Given its binding domains for different growth factors, the addition of heparin is considered a functionalization strategy that enables the capture and concentration of the circulating angiogenic growth factors released during vascular injury.
Several efforts are focused on the surface functionalization of polymers to allow immobilization and long-term delivery of growth factors for differentiation purposes [9, 36] . However, heparin itself has an important effect on endothelial differentiation and homeostasis and has been demon strated to promote endothelial commitment in bone marrow stem cells, even in conditions of organ damage [37] , without the drawbacks related to undesirable effects of other growth factors, which could potentially hamper the clinical translation of the constructs.
Our aim was to exploit these properties and to develop an ad hoc differentiating device for autologous stem cells, able, at the same time, to facilitate and optimize the management of the construct once in the clinical setting. The concept of fabricating a scaffold containing factors, such as heparin, able to induce stem cell differentiation and to exert important systemic effects was pursued; this material could represent an alternative to the commonly used TEVGs with mature, fully differentiated autologous endothelial cells, in order to improve clinical management.
Recently, our group has developed a hydroxyapatite functionalized electrospun PLLA scaffold with the aim to recapitulate the native histoarchitecture and the molecular signaling of osteochondral tissue to facilitate cell differentiation towards chondrocytes. PLLA/hydroxyapatite future science group nanocomposites induced differentiation of hMSCs in a chondrocyte-like phenotype with the generation of a proteoglycan-based matrix [16] . Moreover, we produced data on a scaffold tailored for cardiovascular structures [15, 38] . These data represent a proof of principle of the possibility to produce a scaffold suitable for stem cell seeding, containing the appropriate factors to induce a guided differentiation towards the desired phenotype. In this setting, differentiation would be realized within a 3D ECM-like environment closely mimicking the native tissue architecture and allowing a harmonious ongoing cell growth and differentiation for tissue regeneration. Guided differentiation of an easily recruitable, highly plastic stem cell type (e.g., hMSCs) could overcome the current difficulties related to the low cell yields and quality, mainly due to the patients general conditions (i.e., age, smoking and diabetes) [13, 39] .
Scaffolds were developed by means of electrospinning, within the direct incorporation of the biomolecule in the polymer solution, thus overcoming the drawbacks of other methods, such as adsorption or microencapsulation [40] .
Electrospun materials are highly sensitive at small variations in electrostatic and rheological properties of the starting solutions, which may reflect in alterations of the final morpho logy. FE-SEM characterization, in fact, revealed substantial changes between PLLA/Hep and PLLA/ctrl fibers. In PLLA/Hep samples, addition of the drug and co-solvent caused a decrease in polymer solution viscosity, leading to smoother and thinner fibers. These fibers did not show intrinsic nanosized porosity that characterized fibers in bare PLLA, attributable to a phase separation process during solvent evaporation. Nevertheless, both scaffolds retained adequate porosity between the fibers. This arrangement could provide a favorable environment to cell attachment, growth and differentiation by closely mimicking the structure of native ECM recapitulating the arrangement of connective tissue fibrillar proteins [8] .
As an additional control, to assess whether the previously cited differences in fiber morphology may affect the differentiation of stem cells cultured within the scaffolds, a set of experiments were also performed on 2D cultures with cells adhered to conventional plastic ware that were exposed to the scaffolds by means of transwell inserts. Heparin release kinetics were evaluated. The release profile demonstrated an increased steepness following the first 24 h, indicating an initial releasing burst, reliably associated with excess drug removal immediately after immersion of the scaffold in PBS, and a further sustained release, involving swelling of the polymer network and diffusion of the drug. This kinetic profile could represent an advantage for eventual clinical applications as providing an immediate high-dose heparin release would potentially be able to counteract the well-known initial thrombotic tendency soon after surgical vascular anastomosis, a common reason for early graft failure. Further calculation of the effective amount of heparin released during the first 48 h following the seeding revealed a final drug concentration of 12 µg/ml. It is worth noting that this concentration has been used in previous studies demonstrating endothelial differentiation induced by the addition of heparin to the culture media [41] . Moreover, released heparin retained its biological functionality, as demonstrated by ACT results. Tensile behavior of the electrospun material, as assessed from circumferential and longitudinal tensile tests, was compatible with the model of a fibrillar material. According to the model, fibers are progressively recruited by imposed strain, resulting in an increase in the steepness of the stress-strain curve. At highstress values, progressive failure of fiber elements is experienced. These phenomena result in a bell-shaped stress-strain curve, similar to the one provided in Figure 3 for the sample under circumeferential loading.
Burst pressure, as calculated from ultimate tensile stress according to Nieponice et al. [22] , was still significantly lower than the native saphenous vein [23] , as well as suture retention force. The authors acknowledge that further optimization is still needed to improve mechanical properties to closely match the native tissue. This could possibly be obtained by tailoring the thickness of the electrospun layer and/or the orientation of the electrospun fibers. Moreover, the evaluation of mechanical properties for cellularized scaffolds throughout engineered tissue formation has to be performed, and will be the focus of further investigations.
Results of confocal microscopy of scaffolds seeded with hMSCs were consistent with adequate cell attachment and viability; in the drugloaded scaffold (PLLA/Hep), morphostructural changes were observed, resulting in cell elongation, reduction in cytoplasm with nuclear enlargement, increase in nucleoli number and appearance of membrane invaginations resembling typical endothelial caveolae.
Proliferation ana lysis confirmed the generation of a nonhostile microenvironment for cell culturing, with an additional proliferative drive reliably induced by the functionalized scaffold. Along with these findings, in the PLLA/Hep scaffolds a shift towards CD31 positivity could be detected in comparison to PLLA/ctrl, thus indicating a possible endothelial commitment. This finding was confirmed by flow cytometry and is consistent with previous reports describing an increased presence of CD31-positive microvessels following subcutaneous application of a covalently bonded heparin-modified porous polyurethane scaffold [42] . An additional marker of endothelial differentiation, vWF, was found to be positively expressed after 1 week of culturing, confirming stem cell differentiation induction.
Experiments performed using transwell inserts, with cells only exposed to PLLA/Hep and PLLA/ctrl elution products, and still indicating expression of CD31 in the presence of heparin, proved that the differentiative stimulus is derived from the drug, and not from differences in fiber morphology, which was envisaged between PLLA/Hep and PLLA/ctrl scaffolds.
Together, these findings support our data concerning the ability of the heparinized scaffold to induce stem cell differentiation towards vascular endothelium.
Furthermore, the well-reported effect of heparin in the inhibition of smooth muscle cell proliferation and intimal hyperplasia could allow for speculation on the possible efficacy of this scaffold in the modulation of these phenomena, which are causes of graft restenosis [43, 44] , and will be the subject of further investigation.
Extended experiments culturing constructs for an additional week demonstrated the permanence of the acquired CD31-positive phenotype and the expression of vWF. From confocal ana lysis, the latter demonstrated a membrane, future science group cytoplasmic and perinuclear localization, reliably suggestive of an immature form of the protein waiting for its definitive migration at the membrane site. Presence of vWF at the 1 week time point, together with its subcellullar localization could be considered as intermediate steps along the differentiation pathway, allowing for speculation on the ongoing maturation of the endothelial phenotype acquired by hMSCs in these settings. The intrinsic properties of the proposed scaffolds could provide the correct sequences of signals to promote cell adhesion and matrix remodeling, creating a microenvironment able to not only assist and guide cell growth, differentiation and repopulation but also able to mimic the mechanical properties of the native tissue, providing at the same time important signaling once in the in vivo settings.
The main concept emerging from this work concerns the idea of designing an absorbable scaffold able to define an optimal microenvironment to induce tissue-oriented differentiation of stem lineages and, at the same time, to host cells in a structure resembling the natural ECM. In this study we proposed a different approach to tissue engineering, in which the biomaterial is intended as a differentiating system for the stem cell seeded therein, and is capable of guiding and orientating the differentiation process within a 3D biomimetic structure.
Conclusion
We developed an electrospun heparin-releasing PLLA tubular scaffold, in which a single and easily recruitable stem cell or endogenous transmigrated stem cell would encounter an adequate pre constituted environment, promoting differentiation towards the endothelial phenotype.
The electrospinning technique, amenable for functionalization, allowed the fabrication of a structure not only mimicking the morpho logical properties of the native tissue, but even able to assist and guide cell adhesion, growth and differentiation. Moreover, the device can act as a drug-releasing system, delivering factors useful for both the management of the immediate postimplantation period and for the maintenance of a milieu that provides the correct signaling to guarantee tissue homeostasis.
Future perspective
Nowadays, clinical scenarios are evolving towards the treatment of chronic degenerative diseases rather than acute pathologies, and patients undergoing cardiovascular surgery are becoming older and older. Clearly, endo genous regenerative abilities in these subjects are importantly diminished in quantity and quality, with an impaired capacity of tissue restoration and endothelialization of currently available artificial vascular grafts. Tissue engineering research will, therefore, focus on the development of convenient materials, improved in their biological and structural properties, in order to facilitate a regenerative response and graft endothelialization even in those patients whose regenerative abilities are less efficient.
The possibility to exploit tissue engineering methodologies and advances in biofabrication to facilitate and boost endogenous reparative potential will constitute a main point of focus in the future research in regenerative medicine.
Executive summary
A heparin functionalized poly-l-lactide tubular scaffold was developed by electrospinning, to produce a drug delivery system and ad hoc differentiating device suitable for seeding of autologous stem cells. Scaffold functionalization was achieved by direct incorporation of heparin in the polymer solution; biological integrity of the drug was preserved, as confirmed by an anticoagulant activity assay. Heparin release rate showed an initial burst within the first 24 h followed by a further sustained release profile up to 4 weeks. These kinetics could represent an advantage for eventual clinical applications for providing an immediate high-dose heparin release, potentially able to counteract the well-known initial thrombotic tendency soon after surgical vascular anastomosis, which is at the basis of the early graft failure. Total amount of heparin released was quantified as within the range of the concentration known to differentiate mesenchymal stem cells towards endothelium and to exert a trophic effect on endothelial cells. Human mesenchymal stem cells seeded in the heparin-functionalized electrospun scaffolds found an extracellular matrix-like microenvironment able to promote uniform cell engraftment and increase proliferation. Scaffold functionalization with heparin induced a shift towards CD31 positivity and modifications in cell morphology, therefore suggesting a commitment of the mesenchymal stem cells towards an endothelial phenotype. Positivity to a late marker of endothelial differentiation, such as von Willebrand factor after 1 week culturing, although at an immature stage, further strengthens this hypothesis. A heparin-releasing poly-l-lactide tubular scaffold could represent an alternative to the commonly used tissue-engineered vascular grafts with mature, fully differentiated autologous endothelial cells, in order to improve their clinical management and to overcome their actual limitations.
